Delivery Order SPE2DB22D3501-SPE2DB25FVD26
Award Date
4/2/25
Potential Completion Date
4/23/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FASD0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,083.75 firm fixed-price delivery order is for the supply of 4567682283 TIVDAK 40 MG VIALS. The contract has an ultimate completion date of April 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,083.75, is for the delivery of 40 mg vials of the drug TIVDAK. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a $11,956.29 firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of TIVDAK 40 MG VIALS, a medication, with an ultimate completion date of August 12, 2024. The contract has no set-aside designation. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products, including the drug TIVDAK 40 MG VIALS. The award has a ceiling value of $27,898.01 and a completion date of November 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVM13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,083.75 firm fixed-price delivery order is for the supply of 4,568,078,648 units of the drug TIVDAK 40 MG VIALS. The contract has a period of performance through May 20, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of TIVDAK 40 MG VIALS, a pharmaceutical product, and has a ceiling value of $23,912.58. The contract is a firm-fixed price delivery order with an ultimate completion date of October 7, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part...
This is a $6,981.59 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALVEY 40 MG/ML VIALML, a medical product, with a performance period through June 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award with the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,112.20 firm fixed-price delivery order is for the supply of "TALVEY 40 MG/ML VIALML" medical items, with a completion date of January 22, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $23,736.24 contract is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 7, 2025. Amerisourcebergen holds a significant...
This federal contract award, valued at $1,526.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TDVAX VIAL 0.5ML medical supplies, with an ultimate completion date of September 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...